Glycoprotein D adjuvant herpes simplex virus vaccine.

@article{Bernstein2005GlycoproteinDA,
  title={Glycoprotein D adjuvant herpes simplex virus vaccine.},
  author={David I. Bernstein},
  journal={Expert review of vaccines},
  year={2005},
  volume={4 5},
  pages={615-27}
}
Herpes simplex virus (HSV) Type-1 and -2 are common infections that can cause primary and recurrent herpes labialis and genitalis, as well as gingivostomatitis, keratoconjunctivitis, encephalitis, disseminated infections in immunocompromised persons and neonatal infections. Despite several decades of HSV vaccine development, no effective vaccine has been developed until recently. The following review of the genital HSV-2 glycoprotein D (gD2t, t is for truncated) subunit vaccine formulated with… CONTINUE READING